Emerging Infectious Diseases

Emerging Infectious Diseases is a scientific journal published by the U.S. Centers for Disease Control and Prevention (CDC). It is a monthly, open-access, peer-reviewed publication devoted to global developments involving infectious diseases that are newly appearing, returning after a period of reduced activity, or changing in ways that create new public-health concerns. The journal emphasizes the processes and conditions associated with disease emergence, as well as practical approaches to prevention, control, and elimination. The publication serves an international audience of infectious-disease researchers, epidemiologists, microbiologists, clinicians, public-health officials, laboratory specialists, and related professionals. Its subject matter is inherently cross-border: disease emergence may be driven by changes in pathogens, human behavior, travel, ecological conditions, animal-to-human transmission, or gaps in surveillance and control. Within that broad field, the journal provides a venue for research and analysis concerning global instances of emerging and reemerging infections. As a CDC publication, the journal is closely associated with the agency’s public-health mission and its emphasis on evidence, surveillance, outbreak investigation, and disease prevention. Its editorial scope is scientific rather than consumer-oriented, and its value is primarily informational and scholarly rather than commercial. The journal’s open-access model makes its articles available without a subscription barrier, supporting dissemination among researchers and public-health institutions in different countries. Emerging Infectious Diseases is indexed in major biomedical and scientific information services, including Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. These indexing relationships increase the discoverability of its articles within the international research literature. According to the 2023 Journal Citation Reports, the journal had an impact factor of 7.2; this is a publication-performance metric for the journal and not a financial figure. The journal remains an active scientific publication under the CDC’s publishing umbrella. Its principal offering is the Emerging Infectious Diseases periodical itself, supported by its recurring issues, peer-review process, open-access availability, and focus on infectious-disease emergence, prevention, control, and elimination.

Emerging Infectious Diseases is a monthly scientific journal operated within the publishing activities of the U.S. Centers for Disease Control and Prevention. Its purpose is to communicate peer-reviewed research and analysis about infectious diseases that are newly recognized, returning, or changing in ways that have implications for public health. The journal’s scope is global. Rather than limiting coverage to a particular country, pathogen, or clinical specialty, it concentrates on the broader phenomenon of infectious-disease emergence. This includes attention to the circumstances under which diseases appear or reappear, the mechanisms that allow them to spread, and the public-health measures used to prevent, control, or eliminate them. The resulting subject area connects epidemiology, laboratory science, clinical medicine, environmental and population health, and public-health policy. Its institutional setting is significant to the journal’s identity. The CDC is a major U.S. public-health agency, and the journal’s editorial mission is aligned with the agency’s interest in surveillance, investigation, prevention, and control of infectious threats. At the same time, the publication is intended for an international scientific readership and addresses disease events and research from around the world. Emerging Infectious Diseases uses peer review and is distributed as an open-access publication. Open access allows readers to consult its content without a conventional subscription requirement, which is particularly relevant for public-health workers, researchers, and institutions that may have limited access to commercial scientific literature. The journal is also abstracted and indexed in Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus, linking its content to widely used biomedical and multidisciplinary research databases. The publication continues to function as an active journal rather than as a discontinued historical title. Its principal product is the recurring journal, while its broader brand identity rests on the credibility of peer-reviewed scientific communication and on its specialized focus on infectious-disease emergence. The 2023 Journal Citation Reports assigned it an impact factor of 7.2, indicating its visibility within citation-based journal evaluation systems. No separate commercial product portfolio, publicly traded structure, or independent corporate ownership is established in the supplied reference material.

Academic scientific publishing focused on global emerging and reemerging infectious diseases

• Scientific journal

  Emerging Infectious Diseases

  A monthly, open-access, peer-reviewed medical journal published by the U.S. Centers for Disease Control and Prevention. It covers global examples of new and reemerging infectious diseases and gives particular attention to disease emergence, prevention, control, and elimination. The journal is indexed in MEDLINE/PubMed, Science Citation Index Expanded, and Scopus, and is intended for an international research and public-health audience.

1. 1Emerging Infectious Diseases — Wikipediaen.wikipedia.org
2. 2Emerging Infectious Diseases — official websitewwwnc.cdc.gov